Covestro Valuation

Is 1COVD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1COVD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1COVD (€57.39) is trading below our estimate of fair value (€124.38)

Significantly Below Fair Value: 1COVD is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1COVD?

Key metric: As 1COVD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 1COVD. This is calculated by dividing 1COVD's market cap by their current revenue.
What is 1COVD's PS Ratio?
PS Ratio0.8x
Sales€14.15b
Market Cap€10.85b

Price to Sales Ratio vs Peers

How does 1COVD's PS Ratio compare to its peers?

The above table shows the PS ratio for 1COVD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.8x
CRDA Croda International
3x5.1%UK£4.9b
JMAT Johnson Matthey
0.2x-50.4%UK£2.5b
ELM Elementis
1.3x3.4%UK£776.9m
VCT Victrex
2.7x5.8%UK£769.6m
1COVD Covestro
0.8x4.3%€10.9b

Price-To-Sales vs Peers: 1COVD is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (1.8x).


Price to Sales Ratio vs Industry

How does 1COVD's PS Ratio compare vs other companies in the GB Chemicals Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
JMAT Johnson Matthey
0.2x-50.4%US$3.20b
SYNT Synthomer
0.1x5.0%US$338.95m
CAR Carclo
0.2x7.0%US$32.05m
HEIQ HeiQ
0.2xn/aUS$9.61m
No. of Companies6PS01.22.43.64.86+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 1COVD is good value based on its Price-To-Sales Ratio (0.8x) compared to the UK Chemicals industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is 1COVD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1COVD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 1COVD's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1COVD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€57.39
€60.92
+6.1%
4.2%€62.00€53.00n/a12
Nov ’25€58.09
€60.08
+3.4%
6.3%€62.00€50.00n/a13
Oct ’25€54.82
€57.71
+5.3%
7.4%€62.00€50.00n/a14
Sep ’25€55.48
€57.00
+2.7%
7.6%€62.00€50.00n/a14
Aug ’25€54.88
€57.00
+3.9%
7.6%€62.00€50.00n/a14
Jul ’25€54.72
€54.57
-0.3%
13.5%€62.00€38.00n/a14
Jun ’25€48.36
€52.93
+9.4%
13.4%€61.00€38.00n/a14
May ’25€47.74
€53.21
+11.5%
13.3%€61.00€38.00n/a14
Apr ’25n/a
€53.14
0%
13.4%€61.00€38.00n/a14
Mar ’25€50.42
€53.29
+5.7%
13.3%€61.00€38.00n/a14
Feb ’25€48.73
€52.80
+8.4%
13.2%€61.00€38.00n/a15
Jan ’25n/a
€53.73
0%
13.6%€66.00€38.00n/a15
Dec ’24€50.51
€53.73
+6.4%
13.6%€66.00€38.00n/a15
Nov ’24€46.26
€53.93
+16.6%
13.4%€66.00€38.00€58.0915
Oct ’24€51.79
€54.13
+4.5%
13.7%€66.00€38.00€54.8215
Sep ’24€49.36
€52.35
+6.1%
14.5%€66.00€38.00€55.4817
Aug ’24€49.51
€49.24
-0.5%
15.6%€66.00€38.00€54.8817
Jul ’24€47.75
€48.25
+1.0%
15.5%€66.00€38.00€54.7218
Jun ’24€38.29
€46.18
+20.6%
14.7%€65.00€34.00€48.3619
May ’24€39.74
€45.34
+14.1%
15.5%€65.00€34.00€47.7419
Apr ’24€38.03
€44.29
+16.5%
17.4%€64.00€33.00n/a19
Mar ’24€41.51
€42.79
+3.1%
15.7%€60.00€33.00€50.4219
Feb ’24€42.23
€42.37
+0.3%
14.6%€56.00€33.00€48.7319
Jan ’24€36.92
€41.53
+12.5%
15.0%€56.00€31.00n/a19
Dec ’23€37.46
€41.26
+10.2%
15.0%€56.00€31.00€50.5119
Nov ’23€34.39
€41.79
+21.5%
14.9%€57.00€31.00€46.2619

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies